Parametric Portfolio Associates’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $18.3M | Buy |
239,583
+45,067
| +23% | +$3M | 0.01% | 1011 |
|
|
2021
Q4 | $11.7M | Sell |
194,516
-3,102
| -2% | -$171K | 0.01% | 1277 |
|
|
2021
Q3 | $11.1M | Buy |
197,618
+26,429
| +15% | +$1.52M | 0.01% | 1282 |
|
|
2021
Q2 | $10.4M | Sell |
171,189
-16,383
| -9% | -$1.04M | 0.01% | 1363 |
|
|
2021
Q1 | $13.1M | Buy |
187,572
+26,924
| +17% | +$1.92M | 0.01% | 1447 |
|
|
2020
Q4 | $9.61M | Sell |
160,648
-25,667
| -14% | -$1.5M | 0.01% | 1604 |
|
|
2020
Q3 | $11.2M | Buy |
186,315
+13,499
| +8% | +$784K | 0.01% | 1318 |
|
|
2020
Q2 | $9.07M | Buy |
172,816
+28,185
| +19% | +$1.18M | 0.01% | 1463 |
|
|
2020
Q1 | $4.85M | Sell |
144,631
-3,828
| -3% | -$159K | ﹤0.01% | 1753 |
|
|
2019
Q4 | $6.72M | Buy |
148,459
+45,290
| +44% | +$1.92M | ﹤0.01% | 1829 |
|
|
2019
Q3 | $3.93M | Sell |
103,169
-3,461
| -3% | -$138K | ﹤0.01% | 2196 |
|
|
2019
Q2 | $4.64M | Buy |
106,630
+19,567
| +22% | +$831K | ﹤0.01% | 2068 |
|
|
2019
Q1 | $3.31M | Sell |
87,063
-22,826
| -21% | -$891K | ﹤0.01% | 2290 |
|
|
2018
Q4 | $4.73M | Sell |
109,889
-589
| -0.5% | -$27.5K | ﹤0.01% | 1940 |
|
|
2018
Q3 | $5.43M | Buy |
110,478
+26,572
| +32% | +$1.15M | ﹤0.01% | 1961 |
|
|
2018
Q2 | $2.69M | Buy |
83,906
+11,044
| +15% | +$381K | ﹤0.01% | 2472 |
|
|
2018
Q1 | $2.27M | Sell |
72,862
-5,893
| -7% | -$210K | ﹤0.01% | 2532 |
|
|
2017
Q4 | $3.6M | Sell |
78,755
-17,749
| -18% | -$703K | ﹤0.01% | 2167 |
|
|
2017
Q3 | $3.62M | Sell |
96,504
-13,620
| -12% | -$548K | ﹤0.01% | 2128 |
|
|
2017
Q2 | $5.25M | Buy |
110,124
+21,880
| +25% | +$1.02M | 0.01% | 1730 |
|
|
2017
Q1 | $4.02M | Buy |
88,244
+32,009
| +57% | +$1.38M | 0.01% | 1940 |
|
|
2016
Q4 | $1.82M | Buy |
56,235
+9,864
| +21% | +$329K | ﹤0.01% | 2433 |
|
|
2016
Q3 | $1.59M | Buy |
46,371
+28,648
| +162% | +$1.12M | ﹤0.01% | 2504 |
|
|
2016
Q2 | $598K | Sell |
17,723
-4,289
| -19% | -$211K | ﹤0.01% | 3091 |
|
|
2016
Q1 | $1.17M | Buy |
22,012
+461
| +2% | +$27K | ﹤0.01% | 2815 |
|
|
2015
Q4 | $1.66M | Buy |
21,551
+4,995
| +30% | +$283K | ﹤0.01% | 2376 |
|
|
2015
Q3 | $680K | Sell |
16,556
-241
| -1% | -$14.8K | ﹤0.01% | 2564 |
|
|
2015
Q2 | $1.19M | Sell |
16,797
-5,809
| -26% | -$457K | ﹤0.01% | 2665 |
|
|
2015
Q1 | $2.01M | Buy |
22,606
+3,363
| +17% | +$341K | ﹤0.01% | 2241 |
|
|
2014
Q4 | $1.71M | Sell |
19,243
-1,262
| -6% | -$119K | ﹤0.01% | 2333 |
|
|
2014
Q3 | $1.99M | Buy |
20,505
+16,365
| +395% | +$1.59M | ﹤0.01% | 2079 |
|
|
2014
Q2 | $380K | Buy |
+4,140
| New | +$315K | ﹤0.01% | 3387 |
|
Other funds holding PCRX
SCM
SIMG
FCM